Cell Source, Inc. CLCS OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score

18/100

0/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Cell Source, Inc. (CLCS) 有 12 个已识别的同行可供比较在 Healthcare 板块. 同行包括 ANGN, APGN, ATRX, BDRX, CDIO, EFTR 等.

CLCS 的市值为 $36.03M, 而同行平均市值为 $44.57M.

同行与相似公司 — CLCS

ANGN

Angion Biomedica Corp.

Adhera Therapeutics, Inc.

$0.00 0.00% $722.00

BDRX

Biodexa Pharmaceuticals Plc

$3.43 +5.54% $575.41K

CDIO

Cardio Diagnostics Holdings, Inc.

$2.01 +4.69% $3.72M

EFTR

eFFECTOR Therapeutics, Inc.

$0.00 0.00% $941.00

ELYM

Eliem Therapeutics, Inc.

$5.11 -0.97% $342.68M

EMMA

Emmaus Life Sciences, Inc.

$0.01 +7.53% $701.88K

KTTA

Pasithea Therapeutics Corp.

$0.72 -8.61% $5.37M

LABP

Landos Biopharma, Inc.

$22.93 +0.57% $71.68M

Navidea Biopharmaceuticals, Inc.

$0.00 0.00% $10.01K

其他人也在看

PRAX

Praxis Precision Medicines, Inc.

$339.93

-1.07%

ELYM

Eliem Therapeutics, Inc.

$5.11

-0.97%

LABP

Landos Biopharma, Inc.

Sigilon Therapeutics, Inc.

$22.47

-2.56%

XFOR

X4 Pharmaceuticals, Inc.

$4.33

+3.10%

ANGN

Angion Biomedica Corp.

Cell Source, Inc. CLCS OTC

同行与相似公司 — CLCS

其他人也在看

获取低估股票提醒